Open Innovation Partnership Opportunity
Partner with Orbia to Transform Inhalation Medicine
We're looking for dynamic companies to collaborate on innovative solutions in inhalation medicine.
Orbia is a community of companies bound by a common purpose: to advance life around the world. With a rich history spanning over 60 years, Orbia has grown into a global leader in specialized products and innovative solutions, addressing critical challenges in areas such as agriculture, infrastructure, data communications, and—increasingly—health.
Major subsidiaries: Koura Global (Chemicals), Dura-Line (Connectivity), Netafim (Agrotech), Wavin (Construction), Vestolit (Polymers)
Orbia at a glance
Program Objectives
Current innovation challenge focuses on two main objectives:
Inhalation Medicines
Identify innovations in the delivery of active pharmaceutical ingredients (APIs) (Inhalation medicines) to the lungs.
Metered Dose Inhalers
Evaluation of technologies utilizing or enhancing pressurized Metered Dose Inhaler (pMDI) systems.
What We're Looking For
Key Innovation Areas for the Program
Drug Delivery Mechanisms
- Startups developing novel inhalation medicines and drug delivery systems for efficient pulmonary delivery.
- Technologies ensuring precise dosing and deep lung penetration.
- Nanotechnology-enabled delivery systems for enhanced targeting, absorption, and controlled release in the pulmonary system
Therapeutic Applications
- Exploration of systemic treatments delivered via pulmonary routes
Formulation Technologies
- Development of advanced formulations compatible with pressurized metered-dose inhalers (pMDIs).
- Focus on solutions in biologicals, nanotechnology-based solutions, vaccines, and new chemical entities (e.g., Ensifentrine).
Device Innovation
- Advancements in pMDI design to improve patient compliance.
Partner with Orbia
Why You Should Participate in the Program
Global Reach & Resources
Leverage Orbia's extensive global network, manufacturing capabilities, and market access to scale your innovation worldwide
Accelerated Development
Gain strategic R&D, commercialization, and investment support from a global leader to fast-track your solutions.
Impact & Innovation
Drive the future of inhalation medicine, bringing groundbreaking technologies to patients and improving global health outcomes.
Access Orbia Ventures
Explore potential strategic investment and partnership opportunities with Orbia's dedicated Corporate Venture Capital arm.
Join us today
Are you a startup innovating in the field of inhalation medicine?
Do you have a groundbreaking technology that aligns with Orbia’s objectives?
We invite you to explore this unique opportunity to collaborate and drive the future of pulmonary drug delivery.
